DEANN CARPENTER: Open Payments
NPI 1689216905 · HASTINGS, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$153 in 8 payments from 7 companies in 2025. Trend: 2023 $201 · 2024 $269 · 2025 $153
Food & beverage: $153
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $46 |
| Novo Nordisk Inc | 1 | $25 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Merck Sharp & Dohme LLC | 1 | $17 |
| Xeris Pharmaceuticals, Inc. | 1 | $16 |
| ABBVIE INC. | 1 | $15 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15 |
Products named: CAPLYTA, Ozempic, TRINTELLIX, ROTATEQ, GVOKE HYPOPEN, UBRELVY, JARDIANCE.
Industry payments across NE — which companies pay providers there.
